PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 122 filers reported holding PMV PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $20,352,000 | -16.5% | 1,710,265 | 0.0% | 0.43% | -33.2% |
Q2 2022 | $24,371,000 | -31.6% | 1,710,265 | 0.0% | 0.65% | -16.3% |
Q1 2022 | $35,608,000 | -9.9% | 1,710,265 | 0.0% | 0.78% | +11.5% |
Q4 2021 | $39,507,000 | -22.5% | 1,710,265 | 0.0% | 0.70% | -1.3% |
Q3 2021 | $50,966,000 | -12.8% | 1,710,265 | 0.0% | 0.71% | -24.7% |
Q2 2021 | $58,423,000 | +3.9% | 1,710,265 | 0.0% | 0.94% | +10.6% |
Q1 2021 | $56,251,000 | -46.5% | 1,710,265 | 0.0% | 0.85% | -42.4% |
Q4 2020 | $105,198,000 | +73.3% | 1,710,265 | 0.0% | 1.47% | +32.4% |
Q3 2020 | $60,714,000 | – | 1,710,265 | – | 1.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $19,217,000 | 59.24% |
Euclidean Capital LLC | 2,336,909 | $27,809,000 | 25.82% |
OUP Management Co., LLC | 989,232 | $11,772,000 | 18.33% |
Nextech Invest Ltd. | 1,385,807 | $16,491,000 | 5.33% |
Boxer Capital, LLC | 3,163,795 | $37,649,000 | 2.12% |
PERSONAL CFO SOLUTIONS, LLC | 550,342 | $6,549,000 | 1.64% |
Orbimed Advisors | 6,563,077 | $78,101,000 | 1.45% |
RTW INVESTMENTS, LP | 4,356,920 | $51,847,000 | 1.20% |
ACUTA CAPITAL PARTNERS, LLC | 154,500 | $1,839,000 | 0.79% |
Monarch Partners Asset Management LLC | 210,370 | $2,503,000 | 0.75% |